Matches in Wikidata for { <http://www.wikidata.org/entity/Q92134934> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92134934 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92134934 description "bài báo khoa học" @default.
- Q92134934 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92134934 description "scientific article published on 05 March 2019" @default.
- Q92134934 description "wetenschappelijk artikel" @default.
- Q92134934 description "наукова стаття, опублікована 5 березня 2019" @default.
- Q92134934 name "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 name "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 type Item @default.
- Q92134934 label "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 label "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 prefLabel "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 prefLabel "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 P1433 Q92134934-5DB2D099-2BAE-429E-AE98-E05B9CEBAB0B @default.
- Q92134934 P1476 Q92134934-D9EC0CF6-345E-4E5F-8A11-616A2D40229F @default.
- Q92134934 P2093 Q92134934-1CF60125-DB02-48DD-96E9-DA90FA5765A4 @default.
- Q92134934 P2093 Q92134934-B0E83D52-1505-46FA-BA42-4A71C426E901 @default.
- Q92134934 P2093 Q92134934-E7F2E4F6-F4C8-4609-97FA-F7B8225164B7 @default.
- Q92134934 P2093 Q92134934-E92FC258-A5E2-4448-9A3C-6D3EEE8C87E5 @default.
- Q92134934 P304 Q92134934-752E7EEA-B595-4F13-91C5-55CCF309A6F4 @default.
- Q92134934 P31 Q92134934-1972F2E9-9EB7-4213-8459-4EB5FB39BDF4 @default.
- Q92134934 P356 Q92134934-DA17C3BA-A531-4341-8FE9-38904F958E0D @default.
- Q92134934 P433 Q92134934-BBAE6ED4-9D4A-4D49-A919-DC7ED759F447 @default.
- Q92134934 P478 Q92134934-586E27CE-F0CD-4B21-808D-F48E13F77F50 @default.
- Q92134934 P50 Q92134934-DA28618A-4A2E-4AD5-B2DF-F1E7C8381308 @default.
- Q92134934 P577 Q92134934-F0F798BB-03C8-4355-A6DB-D3AD11950B5F @default.
- Q92134934 P698 Q92134934-747C9E41-16A7-4AE3-A4D8-18CC6E25534F @default.
- Q92134934 P356 FON-2018-0878 @default.
- Q92134934 P698 30834780 @default.
- Q92134934 P1433 Q2781597 @default.
- Q92134934 P1476 "Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies" @default.
- Q92134934 P2093 "Gordon Philipp Otto" @default.
- Q92134934 P2093 "Jessie Wang" @default.
- Q92134934 P2093 "Nadia Harbeck" @default.
- Q92134934 P2093 "Sreekanth Gattu" @default.
- Q92134934 P304 "1313-1322" @default.
- Q92134934 P31 Q13442814 @default.
- Q92134934 P356 "10.2217/FON-2018-0878" @default.
- Q92134934 P433 "12" @default.
- Q92134934 P478 "15" @default.
- Q92134934 P50 Q64794765 @default.
- Q92134934 P577 "2019-03-05T00:00:00Z" @default.
- Q92134934 P698 "30834780" @default.